NHS Trust announces 'exciting' new clinical study with Wakefield's GP Federation
The Mid Yorkshire Teaching NHS Trust has said that they are “proud” to be working in partnership with Conexus Healthcare, Wakefield’s GP Federation, to support an exciting new clinical study taking place.
Across Wakefield, GP practices are supporting the study which will focus on patients with Chronic Spontaneous Urticaria (CSU) – a condition that causes recurring hives and swelling, often with significant impact on quality of life.
The research will test a new investigational medicine at two different dose levels to understand whether it can help manage symptoms for people whose CSU persists despite treatment with antihistamines.
The international study involves around 915 participants at more than 300 centres globally – now including Wakefield.
The investigational treatment has already been evaluated in studies involving healthy volunteers and CSU patients in phase one and two studies, and this clinical trial will aim to help build further evidence on its effectiveness and safety.
A spokesperson for the Trust said: “The Trust’s partnership with Conexus Healthcare is a perfect example of this vision in action.
"Working together, we’re enabling greater opportunities for participation in clinical studies and accelerating the delivery of commercial trials across our region.
"This collaborative approach connects primary and secondary care in ways we have never previously achieved – bringing research closer to communities while maintaining the specialist support patients need.”
People may be invited to take part if they’re aged 18 or over, continue to experience symptoms of CSU despite using antihistamines, and meet the study’s medical eligibility criteria - as assessed by the research team
Participants will then undergo screening to confirm whether they can take part.